Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilanterol and Fluticasone Furoate on Exercise Performance
NCT06066606Recruiting
- Start
- Oct 2023
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Vilanterol + fluticasone furoate with Placebo (2 arms). Primary endpoint: Power output during sprint testing at 3 weeks. Started Oct 2023; status: recruiting.
02
Drugs
vilanterolfluticasone
Beyond the preview
Go deeper on NCT06066606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06066606.